M. Nguyenand colleagues reconstructed a heterotypic HER2+ breasttumor model to evaluate the effect of monoclonal antibodies.The authors cultured tumor cells, endothelial cells, bloodmononuclear cells, and tumor-associated fibroblasts in amultichamber chip. Here, ERBB2 is linked to neoplasm.